Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; the page now shows Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T17:46:06.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.4.2, replacing Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T11:52:46.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A minor revision update was added (Revision: v3.4.1) and the previous revision (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T13:30:14.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Glossary visibility was added and QC metadata/revision text updated; these are display-only changes and do not modify study content.
    Difference
    0.2%
    Check dated 2026-01-29T06:53:00.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Administrative updates to the study record dates and minor regulatory text removals were made; there were no changes to core content, eligibility criteria, outcomes, or study design. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-22T04:38:39.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added and the previous Revision: v3.3.3 has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:58:36.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.